Pharmacoepidemiology and Drug Safety
-
Publication Venue For
- Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States.. 27:229-238. 2018
- Continuity of Prescribing and Medication Adherence in Patients with Schizophrenia and Cardiometabolic Comorbidities. 25:207-207. 2016
- Erratum to "Pediatric post-marketing safety systems in North America: Assessment of the current status." [Pharmacoepidemiology and Drug Safety, 24, (2015), 785-792] Doi: 10.1002/pds.3813. 25:110-111. 2016
- Comparing Patient-centered Outcomes after Uterus-conserving Procedures for Uterine Fibroids Using a Linked Electronic Medical Record (EMR)-claims Database. 24:357-357. 2015
- Immunization Status at Discharge from the Neonatal Intensive Care Unit (NICU). 24:13-13. 2015
- Long-Term Outcomes of Vaginal Mesh vs. Native Tissue Repair for Anterior Vaginal Wall Prolapse. 22:12-13. 2013
- Pediatric Pharmacoepidemiology Safety Study with Long-Term Use of Sertraline: The SPRITES Study. 22:333-334. 2013
- Relative Performance of Approaches Handling Immortal Person-Time in Comparative Effectiveness Research: A Simulation Study. 22:3-3. 2013
- Use of Glyburide vs. Insulin for Treatment of Gestational Diabetes in the US, 2000-2010. 22:145-145. 2013
- The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.. 22:700-704. 2013
- Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.. 22:447-458. 2013
- Algorithms to estimate the beginning of pregnancy in administrative databases. 22:16-24. 2013
- Angioedema Events and Use of Drugs That Act on the Renin-Angiotensin-Aldosterone System (RAAS). 21:162-163. 2012
- Characteristics Associated with Delays in Diagnosis of Pompe Disease among Patients Enrolled in the Pompe Registry. 21:456-457. 2012
- Communicating Quantitative Benefit and Risk Summaries in Promotional Labeling or Print Advertising: A Literature Review. 21:220-220. 2012
- Comparative Cardiovascular Safety of Dementia Medications: A Cross-National Study. 21:333-333. 2012
- Confounding Adjustment in a Distributed Data System without Sharing of Individual-Level Data. 21:259-260. 2012
- Response to commentary by Marcus and Gibbons. 21:713-. 2012
- Comparative Cardiovascular (CV) Safety of Dementia Drugs among Medicare Beneficiaries. 20:S122-S123. 2011
- Selecting an Appropriate Comparison Group: Characterizing Treated and Untreated Patients in the Pompe Registry. 20:S176-S176. 2011
- Use and Outcomes of Partial Knee Replacement (PKR) vs Total Knee Replacement (TKR) among Medicare Beneficiaries, 2000-2009. 20:S137-S137. 2011
- Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients.. 20:700-708. 2011
- The role of the c-statistic in variable selection for propensity score models.. 20:317-320. 2011
- Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States. 17:S26-S26. 2008
- Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002).. 16:1255-1267. 2007
- Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis. 16:S183-S183. 2007
- Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.. 16:5-16. 2007
- Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.. 15:710-718. 2006
- Patients willingness to accept risk-benefit trade-offs in treating Crohn's disease. 15:S138-S139. 2006
- Willingness to accept risk-benefit tradeoffs: Pharmacoepidemiology meets preference measurement. 15:S36-S37. 2006
- Frequency of high-risk use of QT-prolonging medications.. 15:361-368. 2006
- Comparing data mining methods on the VAERS database.. 14:601-609. 2005
- Managing the risks of therapeutic products: proceedings of a workshop.. 14:619-628. 2005
- Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.. 14:407-415. 2005
- Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly.. 13:781-787. 2004
- Racial/ethnic variations in non-steroidal anti-inflammatory drug (NSAID) use among patients with osteoarthritis.. 13:683-694. 2004
- Benefit the patient, manage the risk: a system goal.. 13:269-276. 2004
- Improving communication of drug risks to prevent patient injury: proceedings of a workshop.. 12:183-194. 2003
- The need for a national infrastructure to improve the rational use of therapeutics.. 11:319-327. 2002
- Automated support for pharmacovigilance: a proposed system.. 11:121-125. 2002
- A claims data approach to defining an episode of care.. 10:417-427. 2001
- Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States.. 5:333-338. 1996
- Dose-dependent effects of gabapentin and pregabalin on the day of surgery in total hip and knee arthroplasties 2019
- Administrative claims data to support pragmatic clinical trial outcome ascertainment using PCORnet adaptable trial as an example 2018
- Assessment of transfusion-related acute lung injury (TRALI) after blood transfusion 2018
- Chronic myeloid leukemia among veterans from 2006 to 2015: Trends in utilization of tyrosine kinase inhibitors 2018
- Do people understand benefits and risks? Even ineffective treatments for delaying Alzheimer's disease are preferable to "doing nothing" for many older adults 2018
- Electronic health records (EHR) vs Medicare claims data: Comparing the relative completeness of non-fatal outcomes in a linked cohort 2018
- Linking electronic health data in pharmacoepidemiology: Guidance for assessing appropriateness and feasibility 2018
- Long live the "medical data janitors": International data quality assurance practices in distributed data networks 2018
- Predictors of outpatient cardiac rehabilitation referral among hospitalized heart failure patients: The Atherosclerosis Risk in Communities (ARIC) study 2018
- Too many cooks in the kitchen: The association of medication adherence and diabetes control with number and type of prescribing physicians 2018
- Validation of transfusion administrations among potential transfusion-related acute lung injury (TRALI) patients included in the sentinel distributed database 2018
- Assessment of Transfusion-Related Acute Lung Injury after Red Blood Cell, Plasma and Platelet Administration: Initial Results in the Sentinel System 2017
- Expansion of the US FDA Sentinel System to Inpatient Blood Transfusion Data from Hospital Corporation of America: New Surveillance Options 2017
- Heat-Related Outcomes and Medication Use in Older Adults with Heart Failure 2017
- Trends in Pediatric Acetaminophen Exposures Reported to the National Poison Data System in the United States 2017
- Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries 2017
- Childhood Obesity in Relation to Poor Asthma Control and Exacerbations 2016
- Everyone Isn't Average: Quantifying Heterogeneity in Crohn's Disease Patients' Benefit-Risk Tradeoff Preferences 2016
- Global Utilization of Attention Deficit Hyperactivity Disorder Medications - Preliminary Results 2016
- Risk Factors for Major Bleeding Events in Rivaroxaban Users with Atrial Fibrillation: A Nested Case-Control Study 2016
- Initial Prescription Medication for Children with Anxiety: Concordance with Evidence 2015
- Outcomes of Facility-level Use of Ferumoxytol versus Other Intravenous Iron Formulations in Incident Hemodialysis Patients 2015
- Obesity and Metabolic Abnormalities in Antipsychotic Exposed Youth 2013
- Patients' Value of Benefits and Harms of Migraine Treatments 2010